These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23053185)

  • 61. Molecular breakpoints and platelet counts in chronic myeloid leukemia.
    Shepherd PC; Bond C; Allan NC
    Blood; 1992 Jul; 80(2):556-7. PubMed ID: 1378324
    [No Abstract]   [Full Text] [Related]  

  • 62. Portofino International Conference on Chronic Myeloid Leukemia.
    Carella AM; Melo JV; Goldman JM
    Exp Hematol; 2001 Oct; 29(10):1147-56. PubMed ID: 11602316
    [No Abstract]   [Full Text] [Related]  

  • 63. A new case of chronic myeloid leukemia with c3/a2 BCR/ABL junction. Is it really a distinct disease?
    Mittre H; Leymarie P; Macro M; Leporrier M
    Blood; 1997 Jun; 89(11):4239-41. PubMed ID: 9166872
    [No Abstract]   [Full Text] [Related]  

  • 64. BCR-ABL testing in the evaluation of neutrophilia.
    Smith CJ; Ruan GJ; Kluck LA; Maberry M; Go RS
    Am J Hematol; 2024 Aug; 99(8):1651-1654. PubMed ID: 38760992
    [No Abstract]   [Full Text] [Related]  

  • 65. Comment on: Technical Issues Behind Molecular Monitoring in Chronic Myeloid Leukemia.
    Crampe M; Langabeer SE
    Mol Diagn Ther; 2015 Aug; 19(4):251-2. PubMed ID: 26224625
    [No Abstract]   [Full Text] [Related]  

  • 66. Authors' Reply to Crampe and Langabeer: Technical Issues Behind Molecular Monitoring in Chronic Myeloid Leukemia.
    Mattarucchi E; Pallotti F; Casalone R
    Mol Diagn Ther; 2015 Aug; 19(4):253-4. PubMed ID: 26224626
    [No Abstract]   [Full Text] [Related]  

  • 67. [A case of chronic myeloid leukemia with positive CALR gene].
    Han Y; Song Y; Wang Y; Chai Y; Zeng PY; Yue LL; Wu CY
    Zhonghua Xue Ye Xue Za Zhi; 2020 Oct; 41(10):872. PubMed ID: 33190451
    [No Abstract]   [Full Text] [Related]  

  • 68. Chronic myeloid leukaemia presenting with isolated thrombocythaemia, a case revealing its stem cell biology.
    van Kooten Niekerk PB; Roug AS; Petersen CC; Ommen HB; Kjeldsen E; Bendix K; Nyvold CG; Nederby L; Hokland P
    Br J Haematol; 2013 Jul; 162(1):141-4. PubMed ID: 23593974
    [No Abstract]   [Full Text] [Related]  

  • 69. [Properties of leukemic stem cells and treatment strategy for the cure of chronic myelogenous leukemia].
    Minami Y
    Rinsho Ketsueki; 2013 Jun; 54(6):552-8. PubMed ID: 23823094
    [No Abstract]   [Full Text] [Related]  

  • 70. The UK SPIRIT 1 trial in newly diagnosed chronic myeloid leukaemia.
    Gallipoli P; Clark RE; Byrne J; Apperley JF; Milojkovic D; Foroni L; Goldman JM; O'Brien S
    Br J Haematol; 2022 Mar; 196(6):e55-e57. PubMed ID: 34993961
    [No Abstract]   [Full Text] [Related]  

  • 71. [Guideline for management of chronic myeloid leukemia(2013)].
    Chinese Society of Hematology, Chinese Medical Association
    Zhonghua Xue Ye Xue Za Zhi; 2013 May; 34(5):464-70. PubMed ID: 23688765
    [No Abstract]   [Full Text] [Related]  

  • 72. Trends in incidence, primary treatment and survival in chronic myelomonocytic leukaemia: a population-based study of 1359 patients diagnosed in the Netherlands from 1989 to 2012.
    Dinmohamed AG; Brink M; Visser O; Sonneveld P; van de Loosdrecht AA; Jongen-Lavrencic M; de Greef GE
    Br J Haematol; 2015 Nov; 171(3):436-9. PubMed ID: 25854120
    [No Abstract]   [Full Text] [Related]  

  • 73. Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Hochhaus A; Saussele S; Rosti G; Mahon FX; Janssen JJWM; Hjorth-Hansen H; Richter J; Buske C;
    Ann Oncol; 2017 Jul; 28(suppl_4):iv41-iv51. PubMed ID: 28881915
    [No Abstract]   [Full Text] [Related]  

  • 74. [Guideline for the diagnosis and management in the disease monitoring of patients with Chronic Myeloid Leukemia in China (2014)].
    Huang X;
    Zhonghua Xue Ye Xue Za Zhi; 2014 Aug; 35(8):781-4. PubMed ID: 25152139
    [No Abstract]   [Full Text] [Related]  

  • 75. JAK2, 46/1 haplotype and chronic myelogenous leukemia: diagnostic and therapeutic potential.
    Campiotti L; Elli L; Suter MB; Guasti L; Pallotti F
    Clin Chem Lab Med; 2019 Dec; 58(1):e24-e26. PubMed ID: 31339852
    [No Abstract]   [Full Text] [Related]  

  • 76. Cytology of extramedullary haematopoiesis-A rare unanticipated finding in the lymph node of an undiagnosed chronic myeloid leukaemia case.
    Devi D; Keloth T; Manivannan P; Gochhait D; Kekade S; Gudivada V; Siddaraju N
    Cytopathology; 2019 Jul; 30(4):436-439. PubMed ID: 30803090
    [No Abstract]   [Full Text] [Related]  

  • 77. Managing children with chronic myeloid leukaemia.
    Baccarani M
    Br J Haematol; 2015 Jun; 169(5):759-60. PubMed ID: 25430625
    [No Abstract]   [Full Text] [Related]  

  • 78. Chronic myelogenous leukemia: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Baccarani M; Dreyling M;
    Ann Oncol; 2009 May; 20 Suppl 4():105-7. PubMed ID: 19454424
    [No Abstract]   [Full Text] [Related]  

  • 79. [Predictive factors of successful treatment-free remission for patients with chronic myeloid leukemia].
    Takahashi N
    Rinsho Ketsueki; 2014 May; 55(5):489-96. PubMed ID: 24881913
    [No Abstract]   [Full Text] [Related]  

  • 80. [The present status and prospect of diagnosis and treatment of chronic myelogenous leukemia in China].
    Jiang Q; Huang XJ
    Zhonghua Nei Ke Za Zhi; 2013 Oct; 52(10):803-5. PubMed ID: 24378053
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.